Beneficial Effects of Combination Therapy with Olmesartan and Azelnidipine in Murine Polycystic Kidneys

Publisher： Karger

E-ISSN： 1423-0143|32|4|239-249

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.32, Iss.4, 2009-09, pp. : 239-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Combination Therapy of Olmesartan plus Azelnidipine or Hydrochlorothiazide on Renal and Vascular Damage in SHR/NDmcr-cp Rats

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 2, 2011-01 ,pp. : 87-96

Karger

Access to resources Recommend Favorite

Abnormal Tenascin Expression in Murine Autosomal Recessive Polycystic Kidneys

By  

Nephron, Vol. 82, Iss. 3, 1999-06 ,pp. : 261-269

Karger

Access to resources Recommend Favorite

Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy

By  

Cardiorenal Medicine, Vol. 2, Iss. 4, 2012-10 ,pp. : 256-267

Karger

Access to resources Recommend Favorite

Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy

By  

Nephron, Vol. 129, Iss. 2, 2015-01 ,pp. : 143-154

Karger

Access to resources Recommend Favorite

Beneficial Effects of the Rho Kinase Inhibitor Y27632 in Murine Puromycin Aminonucleoside Nephrosis

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 2, 2008-03 ,pp. : 111-121

Karger

Access to resources Recommend Favorite